经尿道等离子体电切治疗前列腺增生

ransurethral Plasmakentic Vaporization of Prostate for Treatment of the Aged BPH Patients at High Risk

目的:探讨治疗前列腺增生(BPH)的方法和疗效。方法:采用经尿道等离子体前列腺切除术(TUPKVP)治疗BPH32例。结果:术中出血少、无水中毒及尿失禁的发生,疗效满意。结论:TUPKVP是继经尿道前列腺电切术和经尿道前列腺电汽化术之后腔内治疗BPH的新疗法。该术式具有安全性高、易掌握、并发症少、疗效确切等优点。

Objective: To discuss the efficacy of transurethraal plasmakentic vaporization of prostate (TUPKVP) for symptomatic benign prostatic hyperplasia (BPH) in the aged patients at high risk. Methods: 32 cases BPH patients at high risk were treated by TUPKVP. Results: The patients had less blood loss and no water intoxication happening during the operation and no incontinence occurring after the operation. Conclusions: TUPKVP is a new treatment for the BPH patient, especially for aged patients at high risk. It has the advantages of high safety, less complications and good efficacy.